Source:http://linkedlifedata.com/resource/pubmed/id/17102085
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2006-11-14
|
pubmed:abstractText |
Mutations in genes encoding mitochondrial succinate dehydrogenase (SDH) are frequently involved in the development of neural crest-derived (NCD) tumors, such as pheochromocytomas (PHEOs) or paragangliomas (PGLs). In this study we report the results of sequencing analysis in leukocyte DNA of patients affected by PHEO/PGL who turned out to be SDH mutation carriers. A nonsense germline heterozygous mutation (Q109X) was found in the exon 4 of the SDHD gene in the index cases of six unrelated families affected by PHEO/PGL. Haplotype analysis showed the presence of a founder effect. Affected patients showed high clinical variability, ranging from monolateral to bilateral glomus tumors, variably associated or not with PGLs or PHEOs. A novel missense SDHD variant, T112I, was also found in one of our families. A new missense G106D mutation, involving a highly conserved amino acid, was found in two sisters affected by bilateral glomus tumors. A P81L mutation associated with abdominal and head and neck PGL was detected in three families. A G12S variant of the SDHD gene was found in one patient affected by a PHEO. The finding of this variant in 3 of 100 control subjects suggests that it is a polymorphism and not a mutation. A novel IVS2-1G>T variant was found at intron 2 of SDHD gene in one patient affected by a glomus tumor. All the tumors associated with SDHD mutations were benign. Conversely, the only mutation we found in SDHB gene (IVS3+1G>A) was associated with a malignant PHEO.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0077-8923
|
pubmed:author |
pubmed-author:BecheriniLL,
pubmed-author:BerniniG PGP,
pubmed-author:CipolliniFF,
pubmed-author:ErcoliniRR,
pubmed-author:GaglianòM SMS,
pubmed-author:GensiniFF,
pubmed-author:GenuardiMM,
pubmed-author:GuerriniLL,
pubmed-author:LaneA EAE,
pubmed-author:MannelliMM,
pubmed-author:MascalchiMM,
pubmed-author:PinzaniPP,
pubmed-author:PratesiCC,
pubmed-author:SestiniRR,
pubmed-author:SimePP,
pubmed-author:TortiFF,
pubmed-author:VinciSS
|
pubmed:issnType |
Print
|
pubmed:volume |
1073
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
183-9
|
pubmed:meshHeading |
pubmed-meshheading:17102085-Amino Acid Sequence,
pubmed-meshheading:17102085-Animals,
pubmed-meshheading:17102085-Germ-Line Mutation,
pubmed-meshheading:17102085-Heterozygote,
pubmed-meshheading:17102085-Humans,
pubmed-meshheading:17102085-Molecular Sequence Data,
pubmed-meshheading:17102085-Paraganglioma,
pubmed-meshheading:17102085-Sequence Homology, Amino Acid,
pubmed-meshheading:17102085-Succinate Dehydrogenase
|
pubmed:year |
2006
|
pubmed:articleTitle |
SDH mutations in patients affected by paraganglioma syndromes: a personal experience.
|
pubmed:affiliation |
Endocrinology Section, Department of Clinical Physiopathology, University of Florence, Viale Pieraccini 6 50139, Florence, and Internal Medicine 2, Pistoia Hospital, Italy. m.mannelli@dfc.unifi.it
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|